Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
Resource Type
Academic Journal
Authors
Ernst SM; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Uzun S; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Department of Respiratory Medicine, Haaglanden Medisch Centrum, Den Haag, the Netherlands.; Paats MS; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; van Marion R; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Atmodimedjo PN; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; de Jonge E; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Aerts JGJV; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; von der Thüsen JH; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Dubbink HJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.; Dingemans AC; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Source
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE